IP Library Granted Patent US 9,340,810
Granted Patent B2
US 9,340,810 · App. 14/006,021 · Granted May 17, 2016

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

Inventors: Yu Zhang (Beijing, CN); Lan Tang (Beijing, CN); Svend Hostgaard Bang Henriksen (Aalborg, DK)
Assignee: Novozymes, Inc.
C12P19/14C07K14/37C12P19/02C12N15/82C12P2203/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,340,810
App. No.
14/006,021
Granted
May 17, 2016
Kind
B2
Abstract

The present invention provides isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also provides nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.

Claims (84)

1. A method for degrading or converting a cellulosic material, said method comprising: treating the cellulosic material with an enzyme composition comprising a GH61 polypeptide having cellulolytic enhancing activity, wherein the GH61 polypeptide is selected from the group consisting of:

(a) a GH61 polypeptide having at least 90% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12;

(b) a GH61 polypeptide encoded by a polynucleotide that hybridizes under at least high stringency conditions with (i) nucleotides 61 to 1062 of SEQ ID NO: 11 or the cDNA of nucleotides 61 to 1062 of SEQ ID NO: 11, or (ii) the full-length complement of (i), wherein high stringency conditions are defined as prehybridization and hybridization at 42° C. in 5×SSPE, 0.3% SDS, 200 micrograms/ml sheared and denatured salmon sperm DNA, and 50% formamide, and washing three times each for 15 minutes using 2×SSC, 0.2% SDS at 65° C.;

(c) a GH61 polypeptide encoded by a polynucleotide having at least 90% sequence identity to nucleotides 61 to 1062 of SEQ ID NO: 11 or the cDNA of nucleotides 61 to 1062 of SEQ ID NO: 11;

(d) a GH61 polypeptide comprising amino acids 21 to 354 of SEQ ID NO: 12; and

(e) a fragment of the GH61 polypeptide of (a), (b), (c), or (d) that has cellulolytic enhancing activity.

2. The method of claim 1 , wherein the cellulosic material is pretreated.

3. The method of claim 1 , further comprising recovering the degraded or converted cellulosic material.

4. The method of claim 3 , wherein the degraded or converted cellulosic material is a sugar.

5. The method of claim 4 , wherein the sugar is selected from the group consisting of glucose, xylose, mannose, galactose, and arabinose.

6. The method of claim 1 , wherein the enzyme composition further comprises one or more enzymes selected from the group consisting of a cellulase, a GH61 polypeptide having cellulolytic enhancing activity, a hemicellulase, an esterase, an expansin, a laccase, a ligninolytic enzyme, a pectinase, a peroxidase, a protease, and a swollenin.

7. The method of claim 1 , wherein the GH61 polypeptide has at least 91% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

8. The method of claim 1 , wherein the GH61 polypeptide has at least 92% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

9. The method of claim 1 , wherein the GH61 polypeptide has at least 93% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

10. The method of claim 1 , wherein the GH61 polypeptide has at least 94% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

11. The method of claim 1 , wherein the GH61 polypeptide has at least 95% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

12. The method of claim 1 , wherein the GH61 polypeptide has at least 96% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

13. The method of claim 1 , wherein the GH61 polypeptide has at least 97% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

14. The method of claim 1 , wherein the GH61 polypeptide has at least 98% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

15. The method of claim 1 , wherein the GH61 polypeptide has at least 99% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

16. The method of claim 1 , wherein the GH61 polypeptide comprises amino acids 21 to 354 of SEQ ID NO: 12.

17. A method for producing a fermentation product, said method comprising:

(a) saccharifying a cellulosic material with an enzyme composition comprising a GH61 polypeptide having cellulolytic enhancing activity, wherein the GH61 polypeptide is selected from the group consisting of: (1) a GH61 polypeptide having at least 90% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12; (2) a GH61 polypeptide encoded by a polynucleotide that hybridizes under at least high stringency conditions with (i) nucleotides 61 to 1062 of SEQ ID NO: 11 or the cDNA of nucleotides 61 to 1062 of SEQ ID NO: 11, or (ii) the full-length complement of (i), wherein high stringency conditions are defined as prehvbridization and hybridization at 42° C. in 5×SSPE, 0.3% SDS, 200 microqrams/ml sheared and denatured salmon sperm DNA, and 50% formamide, and washing three times each for 15 minutes using 2×SSC, 0.2% SDS at 65° C.; (3) a GH61 polypeptide encoded by a polynucleotide having at least 90% sequence identity to nucleotides 61 to 1062 of SEQ ID NO: 11 or the cDNA of nucleotides 61 to 1062 of SEQ ID NO: 11; (4) a GH61 polypeptide comprising amino acids 21 to 354 of SEQ ID NO: 12; and (5) a fragment of the GH61 polypeptide of (1), (2), (3), or (4) that has cellulolytic enhancing activity;

(b) fermenting the saccharified cellulosic material with one or more fermenting microorganisms to produce the fermentation product; and

(c) recovering the fermentation product from the fermentation.

18. The method of claim 17 , wherein the cellulosic material is pretreated.

19. The method of claim 17 , wherein steps (a) and (b) are performed simultaneously in a simultaneous saccharification and fermentation.

20. The method of claim 17 , wherein the enzyme composition further comprises one or more enzymes selected from the group consisting of a cellulase, a GH61 polypeptide having cellulolytic enhancing activity, a hemicellulase, an esterase, an expansin, a laccase, a ligninolytic enzyme, a pectinase, a peroxidase, a protease, and a swollenin.

21. The method of claim 17 , wherein the fermentation product is an alcohol, an organic acid, a ketone, an amino acid, an alkane, a cycloalkane, an alkene, isoprene, polyketide, or a gas.

22. The method of claim 17 , wherein the GH 61 polypeptide has at least 91% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

23. The method of claim 17 , wherein the GH 61 polypeptide has at least 92% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

24. The method of claim 17 , wherein the GH61 polypeptide has at least 93% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

25. The method of claim 17 , wherein the GH61 polypeptide has at least 94% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

26. The method of claim 17 , wherein the GH61 polypeptide has at least 95% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

27. The method of claim 17 , wherein the GH61 polypeptide has at least 96% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

28. The method of claim 17 , wherein the GH61 polypeptide has at least 97% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

29. The method of claim 17 , wherein the GH61 polypeptide has at least 98% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

30. The method of claim 17 , wherein the GH61 polypeptide has at least 99% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

31. The method of claim 17 , wherein the GH61 polypeptide comprises amino acids 21 to 354 of SEQ ID NO: 12.

32. A method of fermenting a cellulosic material, said method comprising: fermenting the cellulosic material with one or more fermenting microorganisms, wherein the cellulosic material is saccharified with an enzyme composition comprising a GH61 polypeptide having cellulolytic enhancing activity, wherein the fermenting of the cellulosic material produces a fermentation product, and recovering the fermentation product from the fermentation, and wherein the GH61 polypeptide is selected from the group consisting of:

(a) a GH61 polypeptide having at least 90% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12;

(b) a GH61 polypeptide encoded by a polynucleotide that hybridizes under at least high stringency conditions with (i) nucleotides 61 to 1062 of SEQ ID NO: 11 or the cDNA of nucleotides 61 to 1062 of SEQ ID NO: 11, or (ii) the full-length complement of (i), wherein high stringency conditions are defined as prehybridization and hybridization at 42° C. in 5×SSPE, 0.3% SDS, 200 microqrams/ml sheared and denatured salmon sperm DNA, and 50% formamide, and washing three times each for 15 minutes using 2×SSC, 0.2% SDS at 65° C.;

(c) a GH61 polypeptide encoded by a polynucleotide having at least 90% sequence identity to nucleotides 61 to 1062 of SEQ ID NO: 11 or the cDNA of nucleotides 61 to 1062 of SEQ ID NO: 11;

(d) a GH61 polypeptide comprising amino acids 21 to 354 of SEQ ID NO: 12; and

(e) a fragment of the GH61 polypeptide of (a), (b), (c), or (d) that has cellulolytic enhancing activity.

33. The method of claim 32 , wherein the cellulosic material is pretreated.

34. The method of claim 32 , wherein the enzyme composition further comprises one or more enzymes selected from the group consisting of a cellulase, a GH61 polypeptide having cellulolytic enhancing activity, a hemicellulase, an esterase, an expansin, a laccase, a ligninolytic enzyme, a pectinase, a peroxidase, a protease, and a swollenin.

35. The method of claim 32 , wherein the fermenting of the cellulosic material produces a fermentation product.

36. The method of claim 35 , further comprising recovering the fermentation product from the fermentation.

37. The method of claim 35 , wherein the fermentation product is an alcohol, an organic acid, a ketone, an amino acid, an alkane, a cycloalkane, an alkene, isoprene, polyketide, or a gas.

38. The method of claim 32 , wherein the GH61 polypeptide has at least 91% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

39. The method of claim 32 , wherein the GH61 polypeptide has at least 92% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

40. The method of claim 32 , wherein the GH61 polypeptide has at least 93% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

41. The method of claim 32 , wherein the GH61 polypeptide has at least 94% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

42. The method of claim 32 , wherein the GH61 polypeptide has at least 95% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

43. The method of claim 32 , wherein the GH61 polypeptide has at least 96% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

44. The method of claim 32 , wherein the GH61 polypeptide has at least 97% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

45. The method of claim 32 , wherein the GH61 polypeptide has at least 98% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

46. The method of claim 32 , wherein the GH61 polypeptide has at least 99% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

47. The method of claim 32 , wherein the GH 61 polypeptide comprises amino acids 21 to 354 of SEQ ID NO: 12.

48. A nucleic acid construct comprising a polynucleotide encoding a GH61 polypeptide having cellulolytic enhancing activity, wherein the polynucleotide is operably linked to one or more heterologous control sequences that direct the production of the polypeptide, and wherein the GH61 polypeptide is selected from the group consisting of:

(a) a GH61 polypeptide having at least 90% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12;

(b) a GH61 polypeptide encoded by a polynucleotide that hybridizes under at least high stringency conditions with (i) nucleotides 61 to 1062 of SEQ ID NO: 11 or the cDNA of nucleotides 61 to 1062 of SEQ ID NO: 11, or (ii) the full-length complement of (i), wherein high stringency conditions are defined as prehybridization and hybridization at 42° C. in 5×SSPE, 0.3% SDS, 200 micrograms/ml sheared and denatured salmon sperm DNA, and 50% formamide, and washing three times each for 15 minutes using 2×SSC, 0.2% SDS at 65° C.;

(c) a GH61 polypeptide encoded by a polynucleotide having at least 90% sequence identity to nucleotides 61 to 1062 of SEQ ID NO: 11 or the cDNA of nucleotides 61 to 1062 of SEQ ID NO: 11;

(d) a GH61 polypeptide comprising amino acids 21 to 354 of SEQ ID NO: 12; and

(e) a fragment of the GH61 polypeptide of (a), (b), (c), or (d) that has cellulolytic enhancing activity.

49. An isolated recombinant host cell comprising the nucleic acid construct of claim 48 .

50. A method of producing a GH61 polypeptide having cellulolytic enhancing activity, said method comprising:

(a) cultivating the recombinant host cell of claim 49 under conditions conducive for production of the GH61 polypeptide; and

(b) recovering the GH61 polypeptide.

51. A transgenic plant, plant part or plant cell transformed with the nucleic acid construct of claim 48 .

52. A method of producing a GH61 polypeptide having cellulolytic enhancing activity, comprising:

(a) cultivating the transgenic plant, plant part or plant cell of claim 29 under conditions conducive for production of the polypeptide; and

(b) recovering the GH61 polypeptide.

53. The nucleic acid construct of claim 48 , wherein the GH61 polypeptide has at least 91% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

54. The nucleic acid construct of claim 48 , wherein the GH61 polypeptide has at least 92% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

55. The nucleic acid construct of claim 48 , wherein the GH61 polypeptide has at least 93% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

56. The nucleic acid construct of claim 48 , wherein the GH61 polypeptide has at least 94% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

57. The nucleic acid construct of claim 48 , wherein the GH61 polypeptide has at least 95% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

58. The nucleic acid construct of claim 48 , wherein the GH61 polypeptide has at least 96% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

59. The nucleic acid construct of claim 48 , wherein the GH61 polypeptide has at least 97% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

60. The nucleic acid construct of claim 48 , wherein the GH61 polypeptide has at least 98% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

61. The nucleic acid construct of claim 48 , wherein the GH61 polypeptide has at least 99% sequence identity to amino acids 21 to 354 of SEQ ID NO: 12.

62. The nucleic acid construct of claim 48 , wherein the GH61 polypeptide comprises amino acids 21 to 354 of SEQ ID NO: 12.

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 19, 2019
From: NOVOZYMES, INC.
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 050084/0932 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2013
From: ZHANG, YU; TANG, LAN; HENRIKSEN, SVEND HOSTGAARD BANG
To: NOVOZYMES INC.
Reel/Frame 031234/0526 →
Priority Claims (1)
WO PCT/CN2011/073275 · Apr 25, 2011 · international
Continuity (2)
Provisional Application 61485358 · May 12, 2011
Related Publication 20140026261A1 · Jan 23, 2014